Book contents
- Frontmatter
- Contents
- PREFACE
- CONTRIBUTORS
- PART ONE ANATOMY AND THE AGING PROCESS
- PART TWO ANESTHESIA AND SEDATION FOR OFFICE COSMETIC PROCEDURES
- PART THREE FILLERS AND NEUROTOXINS
- Chap. 6 FILLERS: PAST, PRESENT, AND FUTURE
- Chap. 7 HYALURONIC ACID FILLERS: HOW STRUCTURE AFFECTS FUNCTION
- Chap. 8 RESTYLANE: GENERAL CONCEPTS
- Chap. 9 THE RESTYLANE FAMILY OF FILLERS: CANADIAN EXPERIENCE
- Chap. 10 THE JUVÉDERM FAMILY OF FILLERS
- Chap. 11 PURAGEN: A NEW DERMAL FILLER
- Chap. 12 PURAGEN: ASIAN EXPERIENCE
- Chap. 13 REVIEW OF COLLAGEN FILLERS
- Chap. 14 HUMAN AND BOVINE COLLAGEN-BASED FILLERS
- Chap. 15 PORCINE COLLAGEN: EVOLENCE
- Chap. 16 CALCIUM HYDROXYLAPATITE (RADIESSE): A FACIAL PLASTIC SURGEON'S APPROACH
- Chap. 17 CALCIUM HYDROXYLAPATITE (RADIESSE): A DERMASURGEON'S APPROACH
- Chap. 18 CALCIUM HYDROXYLAPATITE FOR HAND VOLUME RESTORATION
- Chap. 19 LONG-LASTING FILLERS: HOW STRUCTURE AFFECTS FUNCTION
- Chap. 20 ACRYLIC PARTICLE–BASED FILLERS: ARTEFILL
- Chap. 21 POLY-L-LACTIC ACID FILLERS
- Chap. 22 POLY-L-LACTIC ACID (SCULPTRA) FOR HAND VOLUME RESTORATION
- Chap. 23 BIOALKAMIDE
- Chap. 24 SILICONE
- Chap. 25 AUTOLOGOUS FAT TRANSFER: AN INTRODUCTION
- Chap. 26 SMALL-VOLUME FAT TRANSFER
- Chap. 27 LARGER-VOLUME FAT TRANSFER
- Chap. 28 FAMI TECHNIQUE AND FAT TRANSFER FOR HAND REJUVENATION
- Chap. 29 ADDING VOLUME TO THE AGING FACE: FAT GRAFTING VERSUS FILLERS AND IMPLANTS IN EUROPE
- Chap. 30 FILLERS: HOW WE DO IT
- Chap. 31 CHOOSING A FILLER
- Chap. 32 FILLER COMPLICATIONS
- Chap. 33 NEUROTOXINS: PAST, PRESENT, AND FUTURE
- Chap. 34 BOTOX: HOW WE DO IT
- Chap. 35 COSMETIC BOTOX: HOW WE DO IT
- Chap. 36 BOTOX: BEYOND THE BASICS
- Chap. 37 BOTOX FOR HYPERHIDROSIS
- Chap. 38 DYSPORT
- Chap. 39 NEUROTOXIN ALTERNATIVE: RADIOFREQUENCY CORRUGATOR DENERVATION
- Chap. 40 FILLERS AND NEUROTOXINS IN ASIA
- Chap. 41 FILLERS AND NEUROTOXINS IN SOUTH AMERICA
- PART FOUR COSMETIC APPLICATIONS OF LIGHT, RADIOFREQUENCY, AND ULTRASOUND ENERGY
- PART FIVE OTHER PROCEDURES
- INDEX
- References
Chap. 24 - SILICONE
from PART THREE - FILLERS AND NEUROTOXINS
Published online by Cambridge University Press: 06 July 2010
- Frontmatter
- Contents
- PREFACE
- CONTRIBUTORS
- PART ONE ANATOMY AND THE AGING PROCESS
- PART TWO ANESTHESIA AND SEDATION FOR OFFICE COSMETIC PROCEDURES
- PART THREE FILLERS AND NEUROTOXINS
- Chap. 6 FILLERS: PAST, PRESENT, AND FUTURE
- Chap. 7 HYALURONIC ACID FILLERS: HOW STRUCTURE AFFECTS FUNCTION
- Chap. 8 RESTYLANE: GENERAL CONCEPTS
- Chap. 9 THE RESTYLANE FAMILY OF FILLERS: CANADIAN EXPERIENCE
- Chap. 10 THE JUVÉDERM FAMILY OF FILLERS
- Chap. 11 PURAGEN: A NEW DERMAL FILLER
- Chap. 12 PURAGEN: ASIAN EXPERIENCE
- Chap. 13 REVIEW OF COLLAGEN FILLERS
- Chap. 14 HUMAN AND BOVINE COLLAGEN-BASED FILLERS
- Chap. 15 PORCINE COLLAGEN: EVOLENCE
- Chap. 16 CALCIUM HYDROXYLAPATITE (RADIESSE): A FACIAL PLASTIC SURGEON'S APPROACH
- Chap. 17 CALCIUM HYDROXYLAPATITE (RADIESSE): A DERMASURGEON'S APPROACH
- Chap. 18 CALCIUM HYDROXYLAPATITE FOR HAND VOLUME RESTORATION
- Chap. 19 LONG-LASTING FILLERS: HOW STRUCTURE AFFECTS FUNCTION
- Chap. 20 ACRYLIC PARTICLE–BASED FILLERS: ARTEFILL
- Chap. 21 POLY-L-LACTIC ACID FILLERS
- Chap. 22 POLY-L-LACTIC ACID (SCULPTRA) FOR HAND VOLUME RESTORATION
- Chap. 23 BIOALKAMIDE
- Chap. 24 SILICONE
- Chap. 25 AUTOLOGOUS FAT TRANSFER: AN INTRODUCTION
- Chap. 26 SMALL-VOLUME FAT TRANSFER
- Chap. 27 LARGER-VOLUME FAT TRANSFER
- Chap. 28 FAMI TECHNIQUE AND FAT TRANSFER FOR HAND REJUVENATION
- Chap. 29 ADDING VOLUME TO THE AGING FACE: FAT GRAFTING VERSUS FILLERS AND IMPLANTS IN EUROPE
- Chap. 30 FILLERS: HOW WE DO IT
- Chap. 31 CHOOSING A FILLER
- Chap. 32 FILLER COMPLICATIONS
- Chap. 33 NEUROTOXINS: PAST, PRESENT, AND FUTURE
- Chap. 34 BOTOX: HOW WE DO IT
- Chap. 35 COSMETIC BOTOX: HOW WE DO IT
- Chap. 36 BOTOX: BEYOND THE BASICS
- Chap. 37 BOTOX FOR HYPERHIDROSIS
- Chap. 38 DYSPORT
- Chap. 39 NEUROTOXIN ALTERNATIVE: RADIOFREQUENCY CORRUGATOR DENERVATION
- Chap. 40 FILLERS AND NEUROTOXINS IN ASIA
- Chap. 41 FILLERS AND NEUROTOXINS IN SOUTH AMERICA
- PART FOUR COSMETIC APPLICATIONS OF LIGHT, RADIOFREQUENCY, AND ULTRASOUND ENERGY
- PART FIVE OTHER PROCEDURES
- INDEX
- References
Summary
Injectable liquid silicone (ILS), used worldwide since the 1940s to elevate scars and wrinkles, is the Jekyll and Hyde of dermal implants. Although capable of producing highly desirable and permanent results in capable hands, it is extremely technique-sensitive and easily abused. It has produced highly publicized disfiguring complications, particularly when adulterated and used in large volumes by untrained, nonmedical personnel. The occasional report by credible authors detailing extremely favorable results is overwhelmed by a torrent of lurid accountings of silicone-induced disasters. This disparity has produced rancorous disagreement (largely supported by anecdotal evidence). Advocates of ILS earnestly believe that almost all the horror stories, including death and disfigurement, are due to criminal misuse or media-fanned hysteria often involving agents that are unrelated to silicone. Critics just as earnestly believe that the advocates are lying about the true incidence of complications following proper use.
HOW DOES SILICONE FIT IN TODAY?
If ILS can overcome a reputation tainted by misuse, abuse, adulteration, and substitution of unrelated substances, it may take its place among a variety of agents used in the exponentially growing field of soft tissue augmentation. This process may be facilitated by multiple scientific, regulatory, and product developments, including (1) an exhaustive federal study that could not support an association between silicone and immune-related health conditions; (2) the availability of two types of liquid silicone now approved by the Food and Drug Administration (FDA) for human use as ophthalmologic implant devices; (3) the FDA Modernization Act of 1997, which permits physicians to use drugs and devices for off-label purposes; and (4) proof of concept.
- Type
- Chapter
- Information
- Office-Based Cosmetic Procedures and Techniques , pp. 97 - 106Publisher: Cambridge University PressPrint publication year: 2010